The common polymorphism of apolipoprotein E: Geographical aspects and new pathophysiological relations

Clinical Chemistry and Laboratory Medicine

Volumn 41, Issue 5, 2003, Pages 628-631

  Ulrik Gerdes, Lars ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Apolipoprotein E; Diseases; Evolution; Genetic polymorphism geography

Indexed keywords

APOLIPOPROTEIN E; VITAMIN D;

AGRICULTURE; ALLELE; ALZHEIMER DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; GENE FREQUENCY; GEOGRAPHY; HETEROZYGOTE; HETEROZYGOTE DETECTION; HUMAN; LIPID TRANSPORT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; SOUTHERN EUROPE; VITAMIN D DEFICIENCY;

APOLIPOPROTEINS E; GENE FREQUENCY; GENETICS, POPULATION; GENOTYPE; GEOGRAPHY; HUMANS; POLYMORPHISM, GENETIC; VITAMIN E DEFICIENCY;

EID: 0038341659     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2003.094     Document Type: Article

References (23)

1. Siest G, Bertrand P, Herbeth B, Vincent-Viry M, Schiele F, Sass C, et al. Apolipoprotein E polymorphisms and concentrations in chronic diseases and drug responses. Clin Chem Lab Med 2000; 38:841-52.
2. Mahley RW, Rall SCJ. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000; 1:507-37.
3. Siest G, Zaiou M, Visvikis S. Human apolipoprotein E concentration in reponse to diseases and therapeutic treatments. Drug Dev Res 2002; 56:95-110.
4. Strittmatter WJ, Bova Hill C. Molecular biology of apolipoprotein E. Curr Opin Lipidol 2002; 13:119-23.
5. de Knijff P, van den Maagdenberg AMJM, Frants RR, Havekes LM. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels. Hum Mutation 1994; 4:178-94.
6. Nickerson DA, Taylor SA, Fullerton SM, Weiss KM, Clark AG, Stengård JH, et al. Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene. Genomics Research 2000; 10:1532-42.
7. Weisgraber KH. Apolipoprotein E: structure-function relationships. In: Schumaker VN, editor. Advances in protein chemistry, vol. 45. New York: Academic Press, 1994:249-302.
8. Smith JD. Apolipoprotein E4: an allele associated with many diseases. Ann Med 2000; 32:118-27.
9. Gerdes LU, Gerdes C, Kervinen K, Savolainen M, Klausen IC, Hansen PS, et al. The apolipoprotein E4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction. A substudy of the Scandinavian Simvastatin Survival Study. Circulation 2000; 101:1366-71.
10. Farrar LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. J Am Med Assoc 1997; 278:1349-56.
11. Gerdes LU. Some epidemiological aspects of the common genetic polymorphism of apolipoprotein E. The Faculty of Health Sciences, University of Aarhus, Denmark, 2002.
12. Gerdes LU, Jeune B, Andersen-Ranberg K, Nybo H, Vaupel JW. Estimation of apolipoprotein E genotype-specific relative mortality risks from the distribution of genotypes in centenarians and middle-aged men: apolipoprotein E gene is a "frailty gene", not a "longevity gene". Genet Epidemiol 2000; 19:202-10.
13. Mahley RW, Rall SCJ. Is epsilon4 the ancestral human apoE allele? Neurobiol Aging 1999; 20:429-30.
14. Fullerton SM, Clark AG, Weiss KM, Nickerson DA, Taylor SL, Stengård JH, et al. Apolipoprotien E variation at the sequency haplotype level: implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet 2000; 67:881-900.
15. Gerdes LU, Gerdes C, Hansen PS, Klausen IC, Færgeman O. Are men carrying the apolipoprotein epsilon4- or episilon2 allele less fertile than epsilon3 epsilon3 genotypes? Hum Genet 1996; 98:239-42.
16. Friedman G, Froom P, Sazbon L, Grinblatt I, Shochina M, Tsenter J, et al. Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology 1999; 52:244-8.
17. Finch CE, Sapolsky RM. The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms. Neurobiol Aging 1999; 20:407-28.
18. Wozniak MA, Itzhaki RF, Faragher EB, James MW, Ryder SD, Irwig L. Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus. Hepatology 2002; 26:456-63.
19. Cavalli-Sforza LL, Piazza A. Human genomic diversity in Europe: a summary of recent research and prospects for the future. Eur J Hum Genet 1993; 1:3-18.
20. Gerdes LU, Vestergaard P, Hermann AP, Mosekilde L. Regional and hormone-dependent effects of apolipoprotein E genotype on changes in bone mineral in peri menopausal women. J Bone Miner Res 2001; 16:1906-16.
21. Chapman J, Sylantiev C, Nisipeanu P, Korczyn AD. Preliminary observations on APOE epsilon4 allele and progression of disability in multiple sclerosis. Arch Neurol 1999; 56:1484-7.
22. Kervinen K, Sodervik H, Makela J, Lehtola J, Niemi M, Kairaluoma MI, et al. Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype? Gastroenterology 1996; 110:1785-90.
23. Moysich KB, Freudenheim JL, Baker JA, Ambrosone CB, Bowman ED, Schisterman EF, et al. Apolipoprotein E genetic polymorphism, serum lipoproteins, and breast cancer risk. Mol Carcinog 2000; 27:2-9.